301 related articles for article (PubMed ID: 19132214)
21. Combined antithrombotic therapy.
Good DE
CMAJ; 2008 Jan; 178(3):327; author reply 327-8. PubMed ID: 18227457
[No Abstract] [Full Text] [Related]
22. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
23. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C
Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828
[TBL] [Abstract][Full Text] [Related]
24. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
25. Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Friesen M
Ann Pharmacother; 2008 Oct; 42(10):1521; author reply 1521. PubMed ID: 18765833
[No Abstract] [Full Text] [Related]
26. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
27. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
28. Probing the occult: testing for blood in the stools.
McCarthy DM
Dig Dis Sci; 2010 Jun; 55(6):1503-5. PubMed ID: 20431946
[No Abstract] [Full Text] [Related]
29. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
Collinge CA; Kelly KC; Little B; Weaver T; Schuster RD
J Orthop Trauma; 2012 Oct; 26(10):568-73. PubMed ID: 22441640
[TBL] [Abstract][Full Text] [Related]
30. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
31. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
[TBL] [Abstract][Full Text] [Related]
32. Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications?
Schwartz NE; Albers GW
Curr Neurol Neurosci Rep; 2008 Jan; 8(1):29-34. PubMed ID: 18367036
[TBL] [Abstract][Full Text] [Related]
33. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
34. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.
Weinberger J
Drugs; 2005; 65(4):461-71. PubMed ID: 15733010
[TBL] [Abstract][Full Text] [Related]
36. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
[TBL] [Abstract][Full Text] [Related]
37. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Christiansen CB; Pallisgaard J; Gerds TA; Olesen JB; Jørgensen ME; Numé AK; Carlson N; Kristensen SL; Gislason G; Torp-Pedersen C
BMC Neurol; 2015 Nov; 15():225. PubMed ID: 26525411
[TBL] [Abstract][Full Text] [Related]
38. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
Furlan AJ
Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
[No Abstract] [Full Text] [Related]
39. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.
Benzimra JD; Johnston RL; Jaycock P; Galloway PH; Lambert G; Chung AK; Eke T; Sparrow JM;
Eye (Lond); 2009 Jan; 23(1):10-6. PubMed ID: 18259210
[TBL] [Abstract][Full Text] [Related]
40. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication?
Eng M; Brock G; Li X; Chen Y; Ravindra KV; Buell JF; Marvin MR
Clin Transplant; 2011; 25(2):292-6. PubMed ID: 20529097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
